Transgenic and knockout mice have played a very important role in biomedical research for the development of animal models for human diseases and for addressing many different biological questions. The transgenic mouse core facility of the NYU School of Medicine combines the services and resources of the Skirball Institute and the Cancer Institute. The TgESCF currently provides four basic services: production of transgenic mice by zygote injection, production of ES cell chimeras by blastocyst injection or morula aggregation, rederivation of mouse strains, and sperm cryopreservation. Over the next 5 years, the transgenic facility will continue to provide these services, but will also provide new services such as the generation and genotyping of knockout ES cell lines, embryo cyropreservation, the purification of DMA constructs, and assisted reproduction techniques. In the past year, transgenic mice have been produced using inbred FVB/N and C57BL/6 mice, and ES cell chimeras have been produced by injection of ES cells into C57BL/6 blastocysts. To enable investigators to house pathogen-free animals in the Skirball animal facility, rederivation of mouse strains has continued to be important, especially as new staff are recruited who work with mice. Over the past 10 years the .transgenic facility has generated -3,600 transgenic founders from ~670 DMA constructs (including BAC-based constructs), generated ES cell chimeras from -370 ES cell knockout lines and rederived -460 mutant lines. During the period of the current Cancer Center Support Grant (2002-2006), 251 DNA constructs were injected and 877 founders were obtained, chimeras were made from 143 targeted ES cell clones, and 261 mouse strains were rederived. We also froze sperm from 17 mutant mouse strains. In addition to these services, the core director and coordinator provided researchers with support related to work with transgenic and knockout mice, such as training in mouse husbandry and consultation in transgenic and ES cell approaches.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-31
Application #
8232201
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
31
Fiscal Year
2011
Total Cost
$117,908
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Koh, Hyunwook; Blaser, Martin J; Li, Huilin (2017) A powerful microbiome-based association test and a microbial taxa discovery framework for comprehensive association mapping. Microbiome 5:45
Huang, Chao; Zeng, Xingruo; Jiang, Guosong et al. (2017) XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell. J Hematol Oncol 10:6
Silvera, Deborah; Ernlund, Amanda; Arju, Rezina et al. (2017) mTORC1 and -2 Coordinate Transcriptional and Translational Reprogramming in Resistance to DNA Damage and Replicative Stress in Breast Cancer Cells. Mol Cell Biol 37:
Koetz-Ploch, Lisa; Hanniford, Douglas; Dolgalev, Igor et al. (2017) MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway. Pigment Cell Melanoma Res 30:328-338
Ma, Lijie; Liu, Yan; Landry, Nichole K et al. (2017) Point mutation in D8C domain of Tamm-Horsfall protein/uromodulin in transgenic mice causes progressive renal damage and hyperuricemia. PLoS One 12:e0186769
Morabito, Michael V; Ravussin, Yann; Mueller, Bridget R et al. (2017) Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain. PLoS One 12:e0168226
Wang, Xing; Zhang, Fenglin; Wu, Xue-Ru (2017) Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin. Sci Rep 7:45983
Feig, Jessica L; Mediero, Aranzazu; Corciulo, Carmen et al. (2017) The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin. PLoS One 12:e0188135
Ono, Kentaro; Viet, Chi T; Ye, Yi et al. (2017) Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling. Sci Rep 7:9181
Tsutsumi, Ryouhei; Harizanova, Jana; Stockert, Rabea et al. (2017) Assay to visualize specific protein oxidation reveals spatio-temporal regulation of SHP2. Nat Commun 8:466

Showing the most recent 10 out of 1082 publications